HomeIDXG • OTCMKTS
add
Interpace Biosciences Inc
Previous close
$0.82
Day range
$0.79 - $0.85
Year range
$0.44 - $3.54
Market cap
3.51M USD
Avg Volume
8.08K
P/E ratio
3.12
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 9.23M | -23.33% |
Operating expense | 5.74M | 11.02% |
Net income | -640.00K | -126.26% |
Net profit margin | -6.93 | -134.24% |
Earnings per share | — | — |
EBITDA | -367.00K | -113.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 502.00K | -75.14% |
Total assets | 12.34M | -4.91% |
Total liabilities | 13.55M | -46.79% |
Total equity | -1.21M | — |
Shares outstanding | 4.42M | — |
Price to book | -3.05 | — |
Return on assets | -8.72% | — |
Return on capital | -41.82% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -640.00K | -126.26% |
Cash from operations | 520.00K | -62.96% |
Cash from investing | -201.00K | -2.03% |
Cash from financing | -1.01M | 49.35% |
Net change in cash | -694.00K | 12.48% |
Free cash flow | 606.88K | -29.06% |
About
Founded
1986
Headquarters
Website
Employees
111
